MIMS (Malaysia) drug information results matching Covasc
User Information
NEWS | CME 
 Conflicting Recommendations for Lipid Screening and Management in Children: The Need for Consensus   Community-based lifestyle intervention beneficial in Chinese diabetes, hypertension patients   Recommendations for the Management of Neuropathic Pain Associated With Peripheral Nerve Entrapment   The JUPITER trial: Do the results apply to Asians?   Asian lung cancer vaccine trial resumes after temporary hold   Chinese women largely unaware of heart disease and stroke risk   Coronary CT predicts future cardiac events   Ethnicity is a strong indicator of cardiovascular risk   Gefitinib improves progression-free survival in NSCLC with EGFR mutations   Women's heart attacks differ from men's   Non-HDL Cholesterol: When and how to Treat   Type 1 Diabetes Mellitus in Children and Adolescents   Linagliptin lowers blood sugar in type 2 diabetics   Researchers in Asia point to better sepsis treatments   7th International Symposium on Respiratory Diseases (ISRD)   
MIMS Info PubMed
Results 1-1 of 1 for Covasc (0 seconds)
Other(s): China  HK  India  Indonesia  Malaysia  Phil  S'pore  Taiwan  Thai  US  Vietnam  ALL  
Display: Brief  Full      Search in: Drug Only  All  
Covasc tab® [ CCM Pharmaceuticals ]  [ CCM Pharmaceuticals ] - amlodipine
Indication: 1st-line treatment of HTN & myocardial ischemia whether due to fixed obstruction (stable angina) &/or vasospasm/vasoconstriction (Prinzmetal's or variant angina) of coronary vasculatu...
MIMS Class: Anti-Anginal Drugs Calcium Antagonists 
Interaction  Patient MedInfo  Search PubMed  

 
  
 
China MIMS Online Home Page Hong Kong MIMS Online Home Page India MIMS Online Home Page Indonesia MIMS Online Home Page Malaysia MIMS Online Home Page Philippines MIMS Online Home Page Singapore MIMS Online Home Page Taiwan MIMS Online Home Page Thailand MIMS Online Home Page Vietnam MIMS Online Home Page